Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Mid-Season Influenza Vaccine Effectiveness Against Laboratory-Confirmed Ambulatory Influenza: U.S. Active Component Service Members

Image of 48088663. This report provides an overview of the 2023-2024 mid-season analysis of influenza vaccine effectiveness against medically-attended ambulatory influenza infections.

This Surveillance Snapshot provides an overview of the 2023-2024 mid-season analysis of influenza VE against medically-attended ambulatory influenza infections among active component service members. Data from the Defense Medical Surveillance System, the NHRC’s respiratory surveillance program, and standardized laboratory data provided by the Defense Centers for Public Health–Portsmouth were used for this analysis.1,2 A case test-negative study design was implemented among the population of ACSMs from all services who were tested for influenza between December 1, 2023 and February 23, 2024—the period of peak influenza activity for the season. 

Cases were defined as individuals with a positive influenza result from a rapid antigen, reverse transcription polymerase chain reaction or culture influenza assay. Test-negative controls were individuals with a negative influenza result from a RT-PCR or culture influenza assay. Crude odds ratios were calculated and multivariate logistic regression was used to calculate adjusted ORs (adjusted for sex, age category, prior vaccination [any influenza vaccine in previous 5 years], and month of diagnosis) and 95% confidence intervals. VE estimates were defined as (1 - OR) x 100. 

Click on the table to access a 508-compliant PDF version

There were 3,540 cases—2,794 A (any subtype), 246 A(H3N2), 119 A(H1N1)pdm09, 751 B (any type)—and 16,411 TNCs. TNCs were more likely vaccinated (85.4%) than cases (82.5%). VE varied by influenza type (Table). Statistically significant VE was found against any influenza case with an adjusted VE of 21% (95% CI: 13, 29) and influenza A (any subtype) with an adjusted VE of 26% (95% CI: 18, 34). The VE point estimate against influenza A(H1N1)pdm09 and A(H3N2) showed effectiveness, but did not reach statistical significance (23% [95% CI: -23, 51] and 28% [95% CI: -1, 49], respectively). This mid-season assessment did not find the vaccine to be effective against influenza B ambulatory infections (-5% [95% CI: -30, 15]). 

The results of this analysis show low protection of the 2023-2024 seasonal influenza vaccines against medically-attended influenza A infections that resulted in ambulatory care visits among ACSMs. As these estimates were obtained during the middle of the influenza season, VE estimates and CIs may change when data from the full season are available and sample sizes increase. 

References

  1. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92(12):1900-1904. doi:10.2105/ajph.92.12.1900 
  2. https://www.med.navy.mil/Naval-Medical-Research-Command/R-D-Commands/Naval-Health-Research-Center/Core-Research/Operational-Infectious Diseases/respiratory-surveillance-2023-2024

You also may be interested in...

Article
Jul 1, 2023

Medical Evacuations out of U.S. Central and U.S. Africa Command Among Active and Reserve Components, U.S. Armed Forces, 2022

This report summarizes the nature, numbers, and trends of conditions for which military members were medically evacuated from the U.S. Central Command (CENTCOM) or Africa Central Command (AFRICOM) operations during 2022, with historical comparisons to the previous four years.

Article
Jul 1, 2023

Morbidity Burdens Attributable to Various Illnesses and Injuries Among Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2022

This annual estimate of illness- and injury-related morbidity and health care burdens on the U.S. Armed Forces and MHS updates previous analyses of these burden distributions among active and reserve component service members in deployed settings. This report focuses on the health encounters of service members during deployment to U.S. Central Command ...

Report
Jun 1, 2023

MSMR Vol. 30 No. 6 - June 2023

.PDF | 1.55 MB

This annual issue quantifies the impacts of various illnesses and injuries in 2022 among members of the active component of the U.S. Armed Forces as well as the U.S. Coast Guard; health care burden metrics include the total number of medical encounters, including hospitalizations and ambulatory services, as well as numbers and types of individuals ...

Article
Jun 1, 2023

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries Among Active Component Members, U.S. Armed Forces, 2022

This annual summary uses several health care burden measures to quantify the impacts of various illnesses and injuries in 2022 among members of the active component of the U.S. Armed Forces. Health care burden metrics include the total number of medical encounters, individuals affected, and hospital bed days.

Article
Jun 1, 2023

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries Among Active Component Members, U.S. Coast Guard, 2022

This report employs the same disease classification system and health care burden measures as employed in the MSMR burden analysis of the U.S. Armed Forces active component to quantify the impacts of various illnesses and injuries among members of the active component of the U.S. Coast Guard in 2022.

Report
May 1, 2023

MSMR Vol. 30 No. 5 - May 2023

.PDF | 1023.59 KB

The May 2023 MSMR reintroduces a monthly reportable medical event (RME) summary for the active component and MHS beneficiaries; then features a review of enhanced mpox outbreak case detection among MHS beneficiaries through ESSENCE (Electronic Surveillance System for the Early Notification of Community-based Epidemics); followed by a report on ...

Article
May 1, 2023

Enhanced Mpox Outbreak Case Detection Among MHS Beneficiaries Through Use of ESSENCE (Electronic Surveillance System for the Early Notification of Community-based Epidemics)

A colorized scanning electron microscopic image of the mpox virus on the surface of infected VERO E6 cells

This report describes how ESSENCE, which collects near real-time biosurveillance data globally on U.S. military personnel, monitored the mpox outbreak in 2002 and assesses its detection of confirmed/probable cases among MHS beneficiaries. ESSENCE systematically queries millions of health encounters to detect records of potential public health ...

Article
May 1, 2023

Increasing Incidence Rates of Eosinophilic Esophagitis in Active Component Service Members, U.S. Armed Forces, 2009–2021

A respiratory therapist visualizes the vocal chords of a patient using an endoscopy tool

This study examines the incidence of eosinophilic esophagitis among the active component of the U.S. Armed Forces from 2009 to 2021. Reported prevalence has been increasing worldwide, with a recent meta-analysis estimating 34.2 cases per 100,000 persons.

Skip subpage navigation
Refine your search
Last Updated: May 07, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery